BioLargo Discusses PFAS Commercialization, Garratt-Callahan Partnership, and $1.2 Million in New Engineering Contracts with The Stock Day Podcast

<div>The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB:BLGO)(“the Company”), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. President and CEO of BioLargo Dennis P. Calvert joined Stock Day host Everett Jolly for an interview.</div>